Blog
Technical depth, clinical context, and the standards work happening at the intersection of precision medicine and health interoperability.
Latest Posts
Rural cancer death rates run 14% higher than urban; 5-year survival is 8% lower — and the gap is widening. Why the real divide is distance from specialty resources, and how hub-and-spoke delivery closes it.
Read Post →The case for the Hub and Spoke model — why struggling rural hospitals should take a hard look, and what closure really costs a community.
Read Post →Six clinical solutions — cardiovascular, oncology, pain management, pharmacogenomics, chronic disease, and maternal health — all operational on a single FHIR R6-native platform built to HL7 CodeX mCODE standards.
Read Post →Coming Soon
The clinical case for matching variants to individual agents — erlotinib vs. gefitinib vs. osimertinib — rather than drug classes.
Why we chose FHIR R6 before it was finalized, and what that decision means for interoperability with Epic, Cerner, and any SMART-enabled system.
The same CYP2D6 result matters to the oncologist, the cardiologist, the psychiatrist, and the primary care physician. Here’s why most platforms miss this.